Udayappan, Shanthadevi
Manneras-Holm, Louise
Chaplin-Scott, Alice
Belzer, Clara
Herrema, Hilde
Dallinga-Thie, Geesje M
Duncan, Silvia H
Stroes, Erik S G
Groen, Albert K
Flint, Harry J
Backhed, Fredrik
de Vos, Willem M
Nieuwdorp, Max
Article History
Received: 2 May 2016
Accepted: 4 May 2016
First Online: 6 July 2016
Competing interests
: M.N. and W.M.d.V. are founders, own equity and are in the Scientific Advisory Board of Caelus Pharmaceuticals, The Netherlands; M.N. is in the Scientific Advisory Board of Seres Health, Boston USA; W.M.d.V. is in the Scientific Advisory Board of Chr Hansen Horsholm Danmark and the Nestle Institute for Health Science (NIHS) Lausanne Switzerland. F.B. is a founder of and owns equity in MetaboGen AB, Sweden. The remaining authors declare no conflict of interest.